Benzonatate
Prescriptionالأسماء التجارية: Benzonatate
About This Medication
DESCRIPTION Benzonatate, a non-narcotic oral antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26-nonaoxaoctacosan-28-yl p-(butylamino) benzoate; with a molecular weight of 603.7. Each benzonatate capsule USP,100 mg contains: Benzonatate, USP 100 mg. Each benzonatate capsule USP,200 mg contains: Benzonatate, USP 200 mg. Benzonatate Capsules USP also contain: D&C Yellow 10, gelatin, glycerin, methylparaben, propylparaben, shellac and titanium dioxide. Chemical Structure
المواد الفعالة
| المادة الفعالة | التركيز |
|---|---|
| Benzonatate | - |
المؤشرات العلاجية والاستخدام
الجرعة وطريقة الإعطاء
Side Effects Overview
التحذيرات والاحتياطات
WARNINGS Hypersensitivity Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures. Psychiatric Effects Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking Benzonatate Capsule in combination with other prescribed drugs. Accidental Ingestion and Death in Children Keep Benzonatate Capsules out of reach of children. Accidental ingestion of Benzonatate Capsules resulting in death has been reported in children below age 10. Signs and symptoms of overdose have been reported within 15-20 minutes and death has been reported within one hour of ingestion. If accidental ingestion occurs, seek medical attention immediately (see OVERDOSAGE ).
موانع الاستعمال
CONTRAINDICATIONS Hypersensitivity to benzonatate or related compounds.
Frequently Asked Questions
INDICATIONS AND USAGE Benzonatate Capsule is indicated for the symptomatic relief of cough.
DOSAGE AND ADMINISTRATION Adults and Children over 10 years of age Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given. Benzonatate Capsules should be swallowed whole. Benzonatate Capsules are not to be broken, chewed, dissolved, cut or crushed.
WARNINGS Hypersensitivity Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures. Psychiatric Effects Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking Benzonatate Capsule in combination with other prescribed drugs. Accidental Ingestion and Death in Children Keep Benzonatate Capsules out …
CONTRAINDICATIONS Hypersensitivity to benzonatate or related compounds.
Benzonatate is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Capsule Products
Browse all Capsule products →References & Data Sources
- • DailyMed — Benzonatate drug label (National Library of Medicine)
- • openFDA — Benzonatate label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 197397 (NLM Normalized Drug Names)
- • NDC Directory — Benzonatate (FDA National Drug Code)
إخلاء المسؤولية الطبية
المعلومات الواردة في هذه الصفحة مخصصة للأغراض التعليمية فقط ولا ينبغي استخدامها بديلًا عن المشورة الطبية المتخصصة أو التشخيص أو العلاج.
استشر دائمًا طبيبك أو أي مقدم رعاية صحية مؤهل بشأن أي أسئلة تتعلق بحالة طبية أو دواء.
مصادر البيانات: DailyMed (NLM), openFDA, MFDS